BenQ Materials Creates New Medical Value Through Materials Science: Anscare SIMO Negative Pressure Wound Therapy System Honored with the 2026 Taipei Biotech Awards Innovation Technology Silver Award

In the face of aging demographics, tighter medical staffing, and the paradigm shift toward Enhanced Recovery After Surgery (ERAS), wound care is rapidly expanding from hospitals to homes and communities. BenQ Materials, a global leader in materials science, has earned the prestigious Innovation Technology Silver Award in the Medical Device Category at the 2026 Taipei Biotech Awards for its flagship advanced wound and tissue repair brand, Anscare, and its flagship product—the "Anscare SIMO Negative Pressure Wound Therapy System"—recognizing its exceptional innovation in materials science and clinical application value. This honor not only highlights BenQ Materials’ successful R&D capability in extending its expertise in optoelectronics and polymer materials into advanced medical devices, but also fulfills its commitment to bringing innovative medical technologies directly into clinical practice and patients' daily lives.

"We are deeply honored that the Anscare SIMO Negative Pressure Wound Therapy System has received the Taipei Biotech Award, which is an important validation of BenQ Materials' efforts to extend its materials science capabilities into the medical field," said Jason Chen, Chairman of BenQ Materials. "Starting from actual clinical and patient needs, through the integration of material technology and medical device design, we continuously explore how to make wound care closer to patients' lives. Moving forward, BenQ Materials will continue to invest in the integration of smart monitoring, material technology, and wound care applications, enhancing healthcare efficiency and patient quality of life through innovative technology."
 

Breaking Traditional Frameworks: Creating a Freer Life During Treatment via "Simple & Mobile"

Traditional Negative Pressure Wound Therapy (NPWT) systems have primarily been centered around in-hospital scenarios, where patients' range of motion is often restricted to the bedside due to power and fluid collection constraints. As early patient discharge and outpatient continuous therapy become increasingly essential, "how treatment integrates into daily life" has become a vital issue in contemporary healthcare.

The Anscare SIMO Negative Pressure Wound Therapy System was conceived precisely from this unmet clinical need. Designed around the core concepts of "Simple & Mobile" and through the deep integration of polymer materials science and medical device design, the system features a power-free, canister-free, and showerable design. The Anscare SIMO Negative Pressure Wound Therapy System breaks through the spatial limitations of traditional equipment, extending the application scenario from the bedside into patients' daily lives, transforming patients from individuals confined to their beds into "free-livers" undergoing continuous therapy.
 

Balancing Patient Quality of Life with Frontline Healthcare Efficiency

Truly valuable clinical innovation must not only improve the patient experience but also substantially alleviate the caregiving burden on medical personnel. In clinical practice, the Anscare SIMO Negative Pressure Wound Therapy System has demonstrated significant improvements in operational efficiency—clinical application data shows that the system can effectively reduce dressing changes and related nursing time for medical personnel by up to 86%.

For medical teams, simplified treatment workflows effectively reduce the manpower required for repetitive care, allowing limited professional medical resources to be redirected toward critical or precision treatments requiring greater attention. For patients, minimizing the disruption of treatment on daily life is precisely the win-win value created by the Anscare SIMO Negative Pressure Wound Therapy System.
 

Clinical Case Evidence: Resolving Long-Standing Wound Troubles to Return to Daily Life

Beyond design innovation, the Anscare SIMO Negative Pressure Wound Therapy System has been successfully introduced into multiple clinical departments including general surgery, orthopedics, and obstetrics and gynecology, accumulating a rich portfolio of empirical case studies. For instance, a 76-year-old patient suffering from venous ulcers for three years previously required family accompaniment to make round trips to the hospital three times a week for dressing changes, imposing an immense physical, mental, and caregiving burden. After using the Anscare SIMO Negative Pressure Wound Therapy System, wound exudate was effectively controlled within 7 days, and the wound progressively stabilized and continued to heal within a month, significantly reducing the long-term burden on both the patient and their family.


 

Moving from Material Technology to a Medical Technology Platform to Build a Global Wound Care Ecosystem

The Anscare SIMO Negative Pressure Wound Therapy System has accumulated 24 global patents and successively won domestic and international accolades including the Taiwan Excellence Silver Award, the German Red Dot Design Award, and the National Innovation Award. Winning the Taipei Biotech Award once again testifies to its top-tier strength spanning materials science, medical device design, and clinical application.

Anscare centers its development strategy on becoming the "preferred brand from surgery, wound care to recovery," connecting a complete wound care closed-loop through four major product lines (hemostatic applications, wound care, SIMO negative pressure therapy, and scar care). Moving forward, BenQ Materials will continue to deepen its global market layout and clinical partnerships, bringing high-end medical device innovations originating from Taiwan to the world and helping more patients return to a wonderful daily life during their treatment.